Armand Keating
Net worth: 14 696 $ as of 31/12/2025
Net worth: 14 696 $ as of 31/12/2025
Armand Keating is the founder of panCELLa, Inc. (2015).
Dr. Keating is currently a Director at Tissue Regeneration Therapeutics, Inc. and a Director at Pancella Therapeutics, Inc. Former jobs include Professor at the University of Toronto, President of the American Society of Hematology, President of the American Society for Blood & Marrow Transplantation, Chief Medical Services at Princess Margaret Hospital, and Chief Medical Officer at Roquefort Therapeutics Plc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases 0.18% | 31/01/2025 | 156,740 ( 0.18% ) | 14 696 $ | 31/12/2025 |
| Companies | Position | Start |
|---|---|---|
Tissue Regeneration Therapeutics, Inc.
Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Develops human umbilical cord perivascular cells and other therapy products | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Pancella Therapeutics, Inc.
Pancella Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for genodermatoses | Director/Board Member | 04/07/2022 |
Princess Margaret Hospital
Princess Margaret Hospital Part of Royal Group (United Arab Emirates), Princess Margaret Hospital Dental oncology is a company that specializes in dental oncological and maxillofacial prosthetics, with a focus on head and neck cancer, chemotherapy, malignant hematology, osteonecrosis/MRONJ, and medication-related osteoradionecrosis of the jaw (MRONj). Princess Margaret Hospital offers palliative care and have a High-Risk Oral Lesion Clinic. The clinic is staffed by a team of full-time dentists, clinical associates, clinical fellows, consultants, and support staff. The company is based in Toronto, Canada. The company was founded by David Alexander MacNicol. The CEO is Cho-Ze Joseph Lui. | Chief Tech/Sci/R&D Officer | - |
American Society for Blood & Marrow Transplantation
American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs. | President | - |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | President | - |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Tissue Regeneration Therapeutics, Inc.
Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Develops human umbilical cord perivascular cells and other therapy products | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
American Society for Blood & Marrow Transplantation
American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs. | |
Princess Margaret Hospital
Princess Margaret Hospital Part of Royal Group (United Arab Emirates), Princess Margaret Hospital Dental oncology is a company that specializes in dental oncological and maxillofacial prosthetics, with a focus on head and neck cancer, chemotherapy, malignant hematology, osteonecrosis/MRONJ, and medication-related osteoradionecrosis of the jaw (MRONj). Princess Margaret Hospital offers palliative care and have a High-Risk Oral Lesion Clinic. The clinic is staffed by a team of full-time dentists, clinical associates, clinical fellows, consultants, and support staff. The company is based in Toronto, Canada. The company was founded by David Alexander MacNicol. The CEO is Cho-Ze Joseph Lui. | |
Pancella Therapeutics, Inc.
Pancella Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for genodermatoses | Health Technology |
panCELLa, Inc.
panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops iPSC-derived macrophage cell therapy for inflammatory organ diseases | Commercial Services |
Roquefort Therapeutics Plc
Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Select your edition
All financial news and data tailored to specific country editions